W. L. Gore & Associates: GORE COMPLETES FIRST IN-HUMAN IMPLANTS OF THE GORE VIAFORT VASCULAR STENT

CAUTION: Investigational device. Limited by United States law to investigational use. W. L. Gore & Associates initiates its GORE VIAFORT Device Pivotal Clinical Study for the treatment

Related Keywords

Auckland ,New Zealand ,United States ,Kostenloser Wertpapierhandel ,Andrew Holden ,Theresa Yeoh ,Jill Paine ,Auckland Regional Public Health Service ,Wl Gore Associates ,Drug Administration ,Prnewswire Wl Gore Associates ,Pivotal Clinical Study ,Auckland City Hospital ,Regional Interventional Radiology ,Auckland Regional Public Health ,Breakthrough Device ,Investigational Device Exemption ,Peripheral Business Leader ,Gore ,Associates ,More ,Ompletes ,First ,Human ,Implants ,Iafort ,Ascular ,Tent ,